Found 65 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Observational
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP).The study evaluates treatment outcomes for people with CIDP who have received standard of care therapy for at least three months.Who can participate: Adults aged 18 and older with a neurologist-confirmed diagnosis of CIDP and ongoing treatment for at least three months, who …
18 years or above
All genders
Phase 1/2
Interventional
The purpose of this study is to investigate an investigational medication when combined with novel agents in individuals with relapsed or refractory myeloma. This study includes different substudies, some of which are controlled, while others are independent.This study evaluates how well the investigational medication works when used with other treatments. …
18 years - 90 years
All genders
Phase 3
Interventional
This study investigates chronic pruritus of unknown origin (CPUO).The study evaluates the effectiveness and safety of an investigational medication for CPUO.Who can participate: Adults aged 18 to 90 years with chronic pruritus for at least 6 months may participate. Participants must have severe itch scores and a history of insufficient …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates advanced solid tumors. It evaluates the use of an investigational medication alone or combined with other therapies.The purpose of this study is to assess the safety and effectiveness of the investigational medication in treating advanced solid tumors.Who can participate: Adults aged 18 years and older with advanced …
12 years or above
All genders
Phase 3
Interventional
The purpose of this study is to investigate moderate-to-severe AD. Participants will receive treatment with an investigational medication to evaluate its effects on this condition.This study evaluates the safety and efficacy of the investigational medication when used with topical corticosteroids. It focuses on how well the medication works and its …
18 years - 45 years
All genders
Phase 1/2
Interventional
This study investigates moderate to severe acne. The purpose of this study is to evaluate the safety, effectiveness, and immune response of an investigational mRNA vaccine in adults aged 18 to 45 years.The study will focus on assessing how well the investigational vaccine works and how safe it is for …
16 years - 75 years
All genders
Phase 2
Interventional
This study investigates primary focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD).The purpose of this study is to evaluate the safety and effectiveness of investigational medications compared to placebo in participants with these conditions.Who can participate: Participants aged 16 to 75 years with a biopsy report showing primary FSGS …
18 years or above
All genders
Phase 1
Interventional
This study investigates the condition of relapsed/refractory myeloma. It focuses on understanding more about this condition through the use of an investigational medication.The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. It looks at how well participants tolerate the medication and its overall …
10 years - 65 years
All genders
Phase 3
Interventional
This study investigates sickle-cell disease. It focuses on understanding the effects of an investigational medication in people with this condition.This study evaluates the safety and effectiveness of the investigational medication. The purpose of this study is to gather information on how well the medication works and how safe it is …
12 years or above
All genders
Phase 4
Interventional
This study investigates synovial hypertrophy in individuals with hemophilia A.The study evaluates the effects of a weekly dose of investigational medication over a 12-month period. It focuses on assessing changes in joint conditions related to synovial hypertrophy.Who can participate: Participants must be 12 years or older with moderate to severe …